Skip to main content
. 2019 Feb 3;11(2):137. doi: 10.3390/v11020137

Figure 8.

Figure 8

Efficacy of Favipiravir against EBOV in IFNAGR mice. Mice were challenged with 1.0 × 102 pfu of EBOV then treated with 150 mg/kg of favipiravir twice daily for 8 days. The mice were observed for survival (A), body weight loss (B), and clinical score (C). The asterisk indicates statistical significance (p = 0.015, Fisher’s Exact Test). The bars indicate standard error.